Lionco Pharmaceutical Group CoSHSE:603669 -1.44%46 Operating Margin % is 10.15% as of Mar. 2026, which is 1% below its 10-year median of 10.26. GuruFocus rates SHSE:603669 with a GF Score™ of 46/100 and a GF Value™ of ¥6.80 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 952 Drug Manufacturers companies, Lionco Pharmaceutical Group Co ranks worse than 84.14% on this metric.
The historical rank and industry rank for Lionco Pharmaceutical Group Co's Operating Margin % or its related term are showing as below:
SHSE:603669'
s Operating Margin % Range Over the Past 10 Years
Min: -59.09 Med: 10.26 Max: 23.38
Current: -21.47
SHSE:603669's Operating Margin % is ranked worse than 84.14% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs SHSE:603669: -21.47
Lionco Pharmaceutical Group Co (SHSE:603669) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Lionco Pharmaceutical Group Co Operating Margin % Related Terms
Lionco Pharmaceutical Group Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lionco Pharmaceutical Group Co Operating Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lionco Pharmaceutical Group Co Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Lionco Pharmaceutical Group Co's Operating Margin % falls into.
Lionco Pharmaceutical Group Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lionco Pharmaceutical Group Co (SHSE:603669) has a Operating Margin % of 10.15% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Lionco Pharmaceutical Group Co and its competitors. This is near median its historical median of 10.26. According to the industry distribution chart, Lionco Pharmaceutical Group Co ranks #801 out of 952 companies in the Drug Manufacturers industry, placing it in the top 84.1%.
Is Lionco Pharmaceutical Group Co's Operating Margin % too high?
Lionco Pharmaceutical Group Co's current Operating Margin % of 10.15% is near median its 10-year median of 10.26. The Drug Manufacturers industry median Operating Margin % is 7.58. Lionco Pharmaceutical Group Co's value of 10.15% is 33.9% above this industry median. Based on the distribution chart, Lionco Pharmaceutical Group Co ranks #801 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Lionco Pharmaceutical Group Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lionco Pharmaceutical Group Co's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Lionco Pharmaceutical Group Co ranks #801 out of 952 companies for Operating Margin %. This places Lionco Pharmaceutical Group Co in the lower half of its industry. The industry median Operating Margin % is 7.58. Lionco Pharmaceutical Group Co's value of 10.15% is 33.9% above this benchmark. While the company's 10-year median is 10.26 vs. the industry median of 7.58, Lionco Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lionco Pharmaceutical Group Co's current Operating Margin % of 10.15% is 33.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Lionco Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lionco Pharmaceutical Group Co's current Operating Margin % is 10.15%, which is near median its own 10-year median of 10.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lionco Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co (SHSE:603669) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.80, compared to a current price of ¥5.46 — trading 19.7% below its estimated fair value. The current Operating Margin % is 10.15%, which is near median its 10-year median of 10.26 and 33.9% above the Drug Manufacturers industry median of 7.58. Lionco Pharmaceutical Group Co's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Lionco Pharmaceutical Group Co (SHSE:603669), the current Operating Margin % is 10.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lionco Pharmaceutical Group Co (SHSE:603669) Overvalued in 2026?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥5.46 is trading 19.7% below its estimated GF Value™ of ¥6.80.
GuruFocus considers Lionco Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:603669:
Operating Margin %: 10.15% (near median its 10-year median of 10.26)
GF Value™: ¥6.80 vs. price of ¥5.46 (19.7% below fair value)
Industry Position: 33.9% above the Drug Manufacturers median (#801 of 952)
No single metric tells the full story. See the SHSE:603669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lionco Pharmaceutical Group Co Business Description
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
46GF Score
Get the complete analysis for SHSE:603669
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603669 has been successfully added to your 
